《半日總結》恆指跌10點 藥股抽升 康希諾彈21%
市場觀望美國通脹數據及企業公佈業績,港股早市好淡爭持。恆指低開124點後倒升,曾升86點見19,270點,半日跌10點或0.1%,報19,173點;國指跌9點或0.2%,報6,577點;恆生科技指數跌28點或0.6%,報4,345點。大市半日成交總額458.49億元,滬、深港通南下交易半日淨流入8.81億及淨流出8.62億元人民幣。
科技股方面。阿里(09988.HK)升0.8%報93.75元,騰訊(00700.HK)跌0.2%報334.2元,美團(03690.HK)、小米(01810.HK)、百度(09888.HK)及嗶哩嗶哩(09626.HK)跌0.1%至0.3%,京東(09618.HK)、快手(01024.HK)及網易(09999.HK)升0.3%至0.5%。
金融股方面,匯控(00005.HK)隨外圍銀行股下跌,半日跌0.8%報63.5元,港交所(00388.HK)跌0.2%報311元,友邦(01299.HK)跌0.8%報71.9元,國壽(02628.HK)及招行(03968.HK)跌1.5%及1.8%。
藥股抽升,康希諾(06185.HK)與阿斯利康簽訂疫苗產品供應框架協議,半日股價升21.4%。信達生物(01801.HK)第二季8款產品商業化及總產品收入近14億人幣,半日股價升13.1%。康龍化成(03759.HK)升7.4%,藥明康德(02359.HK)、百濟神州(06160.HK)、中生製藥(01177.HK)及翰森(03692.HK)升4.8%至5.2%,石藥(01093.HK)升3.3%。
車股方面,理想汽車(02015.HK)第二季盈利及第三季交付目標均遜市場預期,股價跌6.1%報166.7元。蔚來(09866.HK)及小鵬(09868.HK)亦跌2.6%及3.1%,吉利(00175.HK)及比亞迪(01211.HK)跌1%及1.4%。
內房股碧桂園(02007.HK)證實有境外債處30天付息寬限期,表示再融資環境惡化面臨階段性流動壓力,股價跌4.4%報1.08元,同系物管股碧服(06098.HK)跌3.6%報7.83元。
其他股份方面,中電信(00728.HK)中期純利升10.2%符預期,股價升10.3%報3.94元。將公佈業績的聯通(00762.HK)升0.4%。九倉置業(01997.HK)反彈3.2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.